EUVIMEDEUVIMED entdecken
Crossref

An engineered oncolytic parapoxvirus induces immunogenic tumor cell death and displays antitumor efficacy by enhancing T cell responses

Qi Li, Jing Lin, Fei Gao, Xinyue Wang, Ying Ma, Chengyi Zhang, Haizhu Wu, Fanglin Zhao, Yinghao Song, Mengshi Xu, Wenqi He, Kui Zhao und 2 weitere

Biochemical Pharmacology · 2026

DOI: 10.1016/j.bcp.2026.118339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026. Verfasst von Qi Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: Oncolytic Virotherapy, Oncolytic Viruses, T-Lymphocytes, Parapoxvirus. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Industrial Innovation Funds of Jilin Province of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oncolytic viruses (OVs) is a class of promising cancer biotherapeutics by selectively lysing tumor cells and stimulating antitumor immunity. However, most OV-based clinical efficacy were often restricted by rapid viral clearance mediated by pre-existing neutralizing antibodies and immunosuppressive tumor microenvironment (TME). These barriers particularly limit the efficient activation of T cell-mediated immune responses, thereby compromising durable systemic antitumor effects. Leveraging the distinctive advantage that oncolytic parapoxvirus ovis (ORFV) does not induce neutralizing antibodies in vivo, we developed an engineered ORFV recombinant through simultaneous deleting multiple virulence-associated genes together with inserting Il15 gene, named ORFVΔ-IL15. This newly generated ORFV recombinant retains full replication competence and significantly potentiating anti-tumor efficacy, which was demonstrated by greater capacity in suppressing tumor growth and metastasis especially in immunologically 'cold' tumors. Mechanistically, ORFVΔ-IL15 reprograms TME by modulating inflammatory cytokines, affecting intratumoral T cell recruitment and redirecting T cell subpopulation distribution. Functionally, ORFVΔ-IL15 could induce T cell involved co-stimulation, tumor antigen presenting and tumor killing, which was illustrated by the finding that antigen-specific, cytotoxic and activated CD8+ T cells were highly enriched in tumor lesions. Notably, systemic antitumor immunity was induced, as abscopal effects against distant untreated tumors have been discovered, indicating that long-term immunological memory has been established. Our findings establish ORFVΔ-IL15 as a novel therapeutic agent that integrates oncolytic and immunoregulatory functions, demonstrating robust tumor-suppressive efficacy and offering a promising strategy for next-generation oncolytic virus engineering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncolytic VirotherapyOncolytic VirusesT-LymphocytesParapoxvirusGenetic EngineeringAnimalsFemaleMiceHumansCell Line, TumorMice, Inbred C57BLCell DeathInterleukin-15

Stichwörter der Autor:innen

Antitumor immunityImmunogenic cell deathOncolytic virusParapoxvirusTumor immune microenvironment

Substanzen

Interleukin-15

Autor:innen und Institutionen

  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jili…
  • Department of Laboratory Animals, College of Animal Science, Jilin University, 130062 Changchun, China.

Förderung

  • Industrial Innovation Funds of Jilin Province of China
  • National Natural Science Foundation of China

Zitieren

APA

Li, Q., Lin, J., Gao, F., Wang, X., Ma, Y., Zhang, C., Wu, H., Zhao, F., Song, Y., Xu, M., He, W., Zhao, K., Liu, G., & Guan, J. (2026). An engineered oncolytic parapoxvirus induces immunogenic tumor cell death and displays antitumor efficacy by enhancing T cell responses. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2026.118339

Vancouver

Li Q, Lin J, Gao F, Wang X, Ma Y, Zhang C, et al. An engineered oncolytic parapoxvirus induces immunogenic tumor cell death and displays antitumor efficacy by enhancing T cell responses. Biochemical Pharmacology. 2026. doi:10.1016/j.bcp.2026.118339

BibTeX
@article{Li2026,
  author = {Li, Qi and Lin, Jing and Gao, Fei and Wang, Xinyue and Ma, Ying and Zhang, Chengyi and Wu, Haizhu and Zhao, Fanglin and Song, Yinghao and Xu, Mengshi and He, Wenqi and Zhao, Kui and Liu, Guowen and Guan, Jiyu},
  title = {An engineered oncolytic parapoxvirus induces immunogenic tumor cell death and displays antitumor efficacy by enhancing T cell responses},
  journal = {Biochemical Pharmacology},
  year = {2026},
  doi = {10.1016/j.bcp.2026.118339}
}
Kostenlos starten →